Buy Lupin, target price Rs 1120: Motilal Oswal Financial Services
Strong run-up in weekly scale with recent breakoutabove 1,000 zones and sector supporting up move.

Lupin, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 48420.51 Crore) operating in Pharmaceuticals sector.
Lupin key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.
Financials
For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 4836.89 Crore, up 8.27 % from last quarter Total Income of Rs 4467.35 Crore and up 29.00 % from last year same quarter Total Income of Rs 3749.40 Crore. Company has reported net profit after tax of Rs 453.33 Crore in latest quarter.
Investment Rationale
Strong run-up in weekly scale with recent breakout above 1,000 zones and sector supporting up move.
Promoter/FII Holdings
Promoters held 47.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 13.93 per cent, DIIs 28.94 per cent.
Download ET Markets APP